Login     Register  
    Home   |   Search   |   Director's Bio   |   About/Contact Us   |   Disclaimer  
BioEndeavor - Empowering Women  
 Home
 About BioEndeavor
 Engaged Thinking
 Engaged Thinking Blog
 Engaged Innovation Case Studies
 Engaged Thinking Academy
 Resources
 Engaged Innovation Directory
Genomics 
Environment/BioEnergy 
Drug Discovery 
Health 
Technology 
Other 
 Add Organization 


Drug Discovery
Tuberculosis Drug Accelerator (TBDA)Go Back  
Organization URL

Organization:
Tuberculosis Drug Accelerator (TBDA)

Year Established: 2012

Profile:
Jointly launched in June 2012 through a collaborative agreement among seven pharmaceutical companies1 and six research institutions2 with support from the Bill & Melinda Gates Foundation, the TBDA partnership targets the discovery of new TB drugs by working together on early-stage research. The long-term goal of the partnership is to create a new TB drug combination that has the potential to cure patients in only one month, compared to the six months of treatment required by existing drugs. Based on the partnership, the participating pharmaceutical companies will open up targeted sections of their compound libraries and share data with other participating pharmaceutical companies and research institutions.

Target Sector:
Drug Discovery

Typology of Knowledge Network:
Other

Knowledge Type / Focus:
Data
Other

Participant Type:
Private Sector

Objective / Knowledge Governance:
Cooperative Research/Product Development


2010-2017 BioEndeavor.Net
Privacy and Security Statement Disclaimer Adding Directory Profiles